US Federal 2025-2026 Regular Session

US Federal House Bill HB7391

Introduced
2/5/26  

Caption

Community Health Center Drug Pricing Protection Act

Impact

If enacted, HB7391 would significantly affect the regulation of drug pricing for health centers, mandating that these centers must never pay above the ceiling price for their medications. This adjustment is expected to alleviate some of the financial pressures that health centers face, particularly those serving low-income communities. The legislation reflects a focused effort to prioritize healthcare access and affordability within federal health policy, especially in light of rising drug prices that can burden healthcare providers.

Summary

House Bill 7391, titled the 'Community Health Center Drug Pricing Protection Act', aims to amend the Public Health Service Act by ensuring that Federally-qualified health centers (FQHCs) are not obligated to pay more than the 340B ceiling price for covered outpatient drugs at the point of purchase. This legislative proposal seeks to enhance the financial viability of health centers, enabling them to provide affordable services to underserved populations. The bill is intended to streamline drug pricing within the healthcare system, making prescription drugs more accessible for community health providers.

Contention

Notable points of contention surrounding this act include concerns from pharmaceutical manufacturers regarding the implications of restricting drug prices at the point of purchase. Proponents of the bill argue that ensuring FQHCs can access affordable medications is critical for maintaining health equity. Meanwhile, opponents may raise issues about the potential impact on drug supply and the financial viability of manufacturers, fearing that limited pricing power could reduce profitability and innovation in drug development. Thus, discussions around the bill may delve into the balance between ensuring access to affordable medications while also considering the interests of pharmaceutical companies.

Companion Bills

No companion bills found.

Previously Filed As

US AB1460

An act to add Section 127472 to the Health and Safety Code, relating to prescription drug pricing.

US HB685

AN ACT relating to the 340B Drug Pricing Program.

US SB1030

Prescription drug pricing; prohibiting certain action. Effective date.

US SB1030

Prescription drug pricing; prohibiting certain action. Effective date.

US SB477

Relative to increasing transparency in the 340B Drug Pricing Program.

US HB3493

Global Fairness in Drug Pricing Act

US HR641

Expressing support for community health centers during National Health Center Week, August 3 through August 9, 2025, and encouraging all Americans to take part in this week by visiting their local community health center and celebrating the important partnership between America's community health centers and the communities they serve.

US HB5256

340B ACCESS Act 340B Affording Care for Communities and Ensuring a Strong Safety-net Act

US SB2283

Relating To Prescription Drugs.

US S0886

Discounted Drug Pricing Study

Similar Bills

No similar bills found.